No headlines found.
No press releases found.
No news found.
The Fund will normally invest at least 80% of its net assets in the equity securities that comprise the IBD Breakout Stocks Index. The Fund generally invests in all of the securities comprising the Index in proportion to the weightings of the securities in the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the performance of the Index. The Index's initial universe consists of the approximately 7,000 equity securities that trade on the New York Stock Exchange, The Nasdaq Stock Market, LLC or NYSE American, LLC. This initial universe is composed of U.S.-listed common stocks and American depositary receipts ("ADRs") issued by small, mid and large capitalization companies. Each security chosen for inclusion in the Index and is assigned a ranking score using IBD's Composite Ranking, based upon the following components Earnings Per Share Rating, Relative Price Strength Rating, Industry Group Relative Strength Rating, Sales Margins Return on Equity ("SMR") Rating, Accumulation Distribution Rating and Percentage Deviation from 52-week Price High. The Index utilizes this ranking score to assign weights, with those stocks with higher rankings receiving larger weights.
Capforce Ibd Breakout Opportunities ETF trades on the ARCA stock market under the symbol BOUT.
As of October 5, 2026, BOUT stock price climbed to $43.59 with 1,039 million shares trading.
BOUT has a market cap of $15.26 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, BOUT traded as high as $49.41 and as low as $28.66.
BOUT has underperformed the market in the last year with a price return of +11.8% while the SPY ETF gained +16.9%. BOUT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -7.3% and +1.0%, respectively, while the SPY returned +4.2% and +1.7%, respectively.
BOUT support price is $42.57 and resistance is $43.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BOUT shares will trade within this expected range on the day.
